B-type natriuretic peptide and renovascular hypertension; is there any relation?
Main Article Content
Renal artery stenosis (RAS) is the most prevalent cause of secondary hypertension (HTN). Percutaneous trans-luminal renal angioplasty (PTRA) is used for both diagnosis and treatment of RAS. As many as one third of RAS cases fail to demonstrate post-PTRA HTN improvement. In this study, brain natriuretic peptide (BNP) was measured for consecutive patients with refractory HTN referred for renal artery angiography and 2 groups of participants (essential HTN and RAS) were compared. BNP was found significantly higher among RAS group than those with essential HTN (P <0.001) and had a good sensitivity (76%) to discriminate RAS from essential HTN. RAS cases also showed a statistically significant decline in BNP level (P <0.001) after PTRA. We concluded that BNP is increased in RAS before intervention, is declined after PTRA, and might be used both as a marker for discriminating RAS from essential refractory HTN and for post-PTRA follow-up.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.